Kinnevik and FPV led a $130m Series C round in Enveda.

Private equity companies Kinnevik and FPV, led a $130m Series C round in Enveda, a biotechnology company, with participation from Dimension Capital, Lux Capital and The Nature Conservancy. “We developed our platform to rapidly expand access to nature’s chemistry to find therapeutics at roughly four times the speed–and it’s already delivering results in the form of a deep and differentiated pipeline. This funding will help us advance multiple candidates to exciting clinical catalysts in the next year, confirming our guiding vision that life’s chemistry is an excellent source for new medicines,” Viswa Colluru, Enveda Founder and CEO.